The Association for the Accreditation of Human Research Protection Programs (AAHRPP) announced that it has awarded five organizations with Full Accreditation. Setting new milestones, in its tenth year, AAHRPP has accredited its first organization in China, first psychiatric hospital, and first federal central IRB. The list also includes two top medical colleges and teaching hospital. Specifically, the following were accredited:
"We are pleased to accredit our first human research protection program at the Beijing YouAn Hospital, Capital Medical University. With China's rapid expansion into clinical trial research we are confident that Beijing YouAn Hospital, Capital Medical University will lead the way for other Chinese institutions to put human safety and wellbeing first by becoming accredited." said Marjorie A. Speers, Ph.D., President and CEO, AAHRPP. Also among first are McLean Hospital and the Veterans Health Administration Central Office Human Research Protections Program, a federal central IRB that reviews multisite studies funded by VA and conducted at local VA facilities. Through the rigorous accreditation process, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to the highest standards for research. The accreditation process typically results in system-wide improvements that enhance protections for research participants and promote high-quality research. Accreditation is available to organizations world-wide that conduct biomedical, behavioral or social sciences research involving human participants.Decisions on accreditation are announced quarterly, and accreditation is valid for three years.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.